Impaired Renal Vein Flow in Atrial Fibrillation: A Potential Risk for Renal Dysfunction

28 August 2023: Clinical Research

Bayram Öztürk ^1ABEF , Kemal Göçer ^2ADE* , Ekrem Aksu ^2ACD , Kamil Doğan ^3ABE

DOI: 10.12659/MSM.941435

Med Sci Monit 2023; 29:e941435

Table 2 Echocardiographic parameters of groups.

	Atrial fibrillation (n=34)	Sinus rhythm (n=34)	p value

RA area, cm	20.72±6.31	13.82±4.35
RA, mm	47.14±11.40	44.24±6.58	0.198
RV area, cm	23.21±5.12	19.44±3.42
TAPSE, mm	20.97±2.74	26.43±2.72
sPAB, mmHg	32.23±15.46	20.56±11.42
TV max, m/s	2.63±0.72	2.06±0.80

IVS, mm	11.62±1.70	11.32±1.62	0.528
PWD, mm	10.60±1.64	10.28±1.48	0.282
End-systolic diameter, mm	34.22±4.64	34.18±2.86	0.900
End-diastolic diameter, mm	48.17±4.27	48.45±4.68	0.648
LA, mm	58.14±12.56	49.55±6.44
LA area, cm	25.44±7.10	17.68±4.52
Ejection fraction, (%)	58.36±5.85	61.27±3.47
IVST – interventricular septum; LA – left atrium; LV – left ventricle; RA – right atrium, RV – right ventricle; PWT – posterior wall thickness; sPAP – systolic pulmonary artery pressure; TAPSE – tricuspid annular plane systolic excursion; TV – tricuspid valve. p